Beijing Tiantan Biological Products Corp Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.021x

Beijing Tiantan Biological Products Corp Ltd cash flow conversion efficiency. Based on the latest financial reports, Beijing Tiantan Biological Products Corp Ltd (600161) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥318.80 Million ≈ $46.65 Million USD) by net assets (CN¥14.95 Billion ≈ $2.19 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Beijing Tiantan Biological Products Corp Ltd (1998–2024)

Cash flow conversion efficiency of Beijing Tiantan Biological Products Corp Ltd from 1998 to 2024. This chart illustrates how Beijing Tiantan Biological Products Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 600161 live share price for real-time trading data and today's change.

Beijing Tiantan Biological Products Corp Ltd Cash Flow Conversion Ratio Explained

Beijing Tiantan Biological Products Corp Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Beijing Tiantan Biological Products Corp Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Tiantan Biological Products Corp Ltd ranked by their cash flow conversion efficiency. Also see Beijing Tiantan Biological Products Corp (600161) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
The a2 Milk Company Ltd AU:A2M	0.035x
Apeloa Pharmaceutical Co Ltd SHE:000739	0.068x
Century Aluminum Company NASDAQ:CENX	0.109x
Rubis SCA PA:RUI	0.102x
Covivio Hotels PA:COVH	0.032x
Tel Aviv Stock Exchange TA:TASE	0.131x
Georg Fischer AG SW:GF	5.659x
Companhia Energética de Minas Gerais MX:CIGN	-0.059x

Annual Cash Flow Conversion Efficiency for Beijing Tiantan Biological Products Corp Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Beijing Tiantan Biological Products Corp Ltd from 1998 to 2024. Review Beijing Tiantan Biological Products Corp free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥14.53 Billion ≈ $2.13 Billion	CN¥819.78 Million ≈ $119.96 Million	0.056x	-69.94%
2023-12-31	CN¥12.75 Billion ≈ $1.87 Billion	CN¥2.39 Billion ≈ $350.26 Million	0.188x	+89.27%
2022-12-31	CN¥11.36 Billion ≈ $1.66 Billion	CN¥1.13 Billion ≈ $164.77 Million	0.099x	+3.84%
2021-12-31	CN¥10.27 Billion ≈ $1.50 Billion	CN¥980.35 Million ≈ $143.46 Million	0.095x	-17.98%
2020-12-31	CN¥6.03 Billion ≈ $882.52 Million	CN¥702.11 Million ≈ $102.74 Million	0.116x	-6.18%
2019-12-31	CN¥5.18 Billion ≈ $757.61 Million	CN¥642.47 Million ≈ $94.01 Million	0.124x	-20.43%
2018-12-31	CN¥4.35 Billion ≈ $636.07 Million	CN¥677.92 Million ≈ $99.20 Million	0.156x	+127.40%
2017-12-31	CN¥3.18 Billion ≈ $465.96 Million	CN¥218.39 Million ≈ $31.96 Million	0.069x	-60.92%
2016-12-31	CN¥2.44 Billion ≈ $357.19 Million	CN¥428.37 Million ≈ $62.68 Million	0.175x	-17.08%
2015-12-31	CN¥2.24 Billion ≈ $327.23 Million	CN¥473.26 Million ≈ $69.25 Million	0.212x	-1.81%
2014-12-31	CN¥2.22 Billion ≈ $324.51 Million	CN¥477.95 Million ≈ $69.94 Million	0.216x	-17.19%
2013-12-31	CN¥2.18 Billion ≈ $318.46 Million	CN¥566.43 Million ≈ $82.89 Million	0.260x	+7.07%
2012-12-31	CN¥1.78 Billion ≈ $260.05 Million	CN¥432.00 Million ≈ $63.22 Million	0.243x	-0.46%
2011-12-31	CN¥1.45 Billion ≈ $211.62 Million	CN¥353.15 Million ≈ $51.68 Million	0.244x	+50.88%
2010-12-31	CN¥1.14 Billion ≈ $167.13 Million	CN¥184.85 Million ≈ $27.05 Million	0.162x	-65.73%
2009-12-31	CN¥949.13 Million ≈ $138.89 Million	CN¥448.23 Million ≈ $65.59 Million	0.472x	+29.34%
2008-12-31	CN¥756.97 Million ≈ $110.77 Million	CN¥276.39 Million ≈ $40.44 Million	0.365x	+72.54%
2007-12-31	CN¥725.57 Million ≈ $106.17 Million	CN¥153.55 Million ≈ $22.47 Million	0.212x	-2.89%
2006-12-31	CN¥708.35 Million ≈ $103.65 Million	CN¥154.36 Million ≈ $22.59 Million	0.218x	+10.72%
2005-12-31	CN¥669.09 Million ≈ $97.91 Million	CN¥131.69 Million ≈ $19.27 Million	0.197x	+13.83%
2004-12-31	CN¥636.79 Million ≈ $93.18 Million	CN¥110.11 Million ≈ $16.11 Million	0.173x	+64.78%
2003-12-31	CN¥599.70 Million ≈ $87.76 Million	CN¥62.93 Million ≈ $9.21 Million	0.105x	-64.06%
2002-12-31	CN¥289.04 Million ≈ $42.30 Million	CN¥84.38 Million ≈ $12.35 Million	0.292x	+81.90%
2001-12-31	CN¥289.68 Million ≈ $42.39 Million	CN¥46.49 Million ≈ $6.80 Million	0.160x	-6.46%
2000-12-31	CN¥279.21 Million ≈ $40.86 Million	CN¥47.90 Million ≈ $7.01 Million	0.172x	+12.68%
1999-12-31	CN¥279.67 Million ≈ $40.92 Million	CN¥42.58 Million ≈ $6.23 Million	0.152x	+70.68%
1998-12-31	CN¥265.80 Million ≈ $38.89 Million	CN¥23.71 Million ≈ $3.47 Million	0.089x	--

About Beijing Tiantan Biological Products Corp Ltd

SHG:600161 China Biotechnology

Market Cap

$3.62 Billion

CN¥24.74 Billion CNY

Market Cap Rank

#4257 Global

#611 in China

Share Price

CN¥12.51

Change (1 day)

-1.26%

52-Week Range

CN¥11.41 - CN¥18.64

All Time High

CN¥74.24